S. Gullapalli
发表
V. S. Lingam,
Dnyaneshwar H. Dahale,
Vijayesh Rathi,
2015,
Journal of medicinal chemistry.
S. Gullapalli,
V. Karande,
M. R. Kandadi,
2010,
Neuropharmacology.
S. Gullapalli,
S. Narayanan,
L. Gharat,
2009,
The Journal of urology.
Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats.
S. Gullapalli,
P. Ramarao,
C. Kaul,
2002,
European journal of pharmacology.
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.
Mahesh Y. Pawar,
Neelima Khairatkar-Joshi,
M. Bajpai,
2012,
Bioorganic & medicinal chemistry letters.
S. Gullapalli,
P. Ramarao,
2002,
Neuropharmacology.
M. Bajpai,
S. Gullapalli,
G. Gudi,
2012,
Bioorganic & medicinal chemistry letters.
S. Gullapalli,
J. Pintar,
L. Devi,
2021,
Cellular and molecular neurobiology.
P. Singh,
S. Gullapalli,
M. K. Gurjar,
2018,
Immunology.
S. Gullapalli,
P. Ramarao,
2002,
European journal of pharmacology.
S. Gullapalli,
L. Devi,
J. Morón,
2010,
Neuropsychopharmacology.
S. Gullapalli,
P. Ramarao,
K. Nemmani,
2002,
Pharmacology Biochemistry and Behavior.
S. Gullapalli,
P. Ramarao,
2002,
Brain Research.
S. Gullapalli,
J. Pintar,
L. Devi,
2021,
Cellular and Molecular Neurobiology.
Neelima Khairatkar-Joshi,
M. Bajpai,
S. Gullapalli,
2013,
Bioorganic & medicinal chemistry letters.
Srinivas Gullapalli,
S. Gullapalli,
2021,
Drug Discovery and Development.
S. Gullapalli,
P. Ramarao,
K. Nemmani,
2001,
Pharmacology, Biochemistry and Behavior.
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.
Mahesh Y. Pawar,
Neelima Khairatkar-Joshi,
M. Bajpai,
2012,
Bioorganic & medicinal chemistry letters.